Single award · contract
Botulism Antitoxin
Award ID: 75A50119C00075
A single federal award, with both ends of the trail linked.
$320.9M
Total award value
Award 75A50119C00075 is a contract from the Department of Health and Human Services to Emergent Biosolutions Canada Inc, $320.9M obligated, FY2019 to FY2027, for Botulism Antitoxin. It is classified as NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals). Source
Award details
Award typeContract
PIID75A50119C00075
Action date2019
Period90 mo
Awarding agencyDepartment of Health and Human Services →
RecipientEmergent Biosolutions Canada Inc →
Place of performance—
CategoryNAICS 325412PSC 6505
Competed?Not recordedSource
Total (exact)$320,923,453
More awards to Emergent Biosolutions Canada Inc
awarded 2019$422.3M
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.